Memantine , an uncompetitive antagonist of N-methyl-d-aspartate receptors , may have a role in managing symptoms associated with dementia in Parkinson 's disease ( PDD ) , although its role in improving patient-reported outcomes ( PROs ) has not been extensively investigated .